A Phoenix man with metastatic castration-sensitive prostate cancer shares how back pain led to a PSA test and how his family helped him cope. Prostate cancer grows slowly, and while 50% of men on ...
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
In the phase 2 MASTERPLAN trial, adding SBRT to chemotherapy lowered the rate of cancer returning near the pancreas from 52.0% to 20.2% at one year.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results